We have studied the contribution of c-Fos/activator protein-1 (AP-1) to antigen-specific T cell response with reference to T cell anergy by increasing c-Fos/AP-1 in vivo and in vitro. First, after injection of a high dose of staphylococcus enterotoxin B (SEB), clonal deletion of SEB-reactive V β 8 ⍣ CD4 T cells occurred both in control B6 and H2-c-fos transgenic (fos) mice, whereas proliferation of T cells against SEB was profoundly depressed in B6 but not in fos mice. Second, the keyhole limpet hemocyanin-specific CD4 T h 1 cell clone produced decreasing amounts of IL-2 in response to increasing amounts of concanavalin A (Con A) in vitro, whereas the decrease was less significant in the T h 1 clones stably transfected with c-fos gene. Electrophoretic mobility shift assay with nuclear protein from the transformants showed that overexpression of the c-fos gene compensated the amounts of AP-1 in the nuclei of Con A-treated T h 1 clones. Thus, increased c-Fos/AP-1 confers resistance against anergy induction on antigen-specific T cells.
Introduction

T cells activated by receptor stimulation in the absence of
The former pathway is downstream of p21 ras . Ras localizes Raf to the membrane where it is phosphorylated and activated. accessory cell-derived co-stimulatory signals lose the capacity to produce IL-2 and to proliferate when re-stimulated with Raf phosphorylates the dual-specific kinase MEK, which subsequently activates extracellular signal-regulated kinase antigen-presenting cell (APC) plus antigen, a state called clonal anergy (1). As to the mechanism of clonal anergy, (ERK) by direct phosphorylation on threonine/tyrosine residues. ERK then up-regulates c-fos through phosphorylation recent findings suggest that activator protein-1 (AP-1) transactivation is defective in anergic T cells. Anergic T cells of Elk-1. The upstream component of the latter JNK pathway is as yet not clearly defined; however, it is thought that the show defective AP-1-dependent transcription and suboptimal binding of AP-1 to the element within the regulatory region of serine/threonine kinase MEKK1 phosphorylates and stimulates the dual-specificity kinase MKK4/SEK1 that phosphorylthe IL-2 gene (1,2). Poor inducibility of c-Fos, FosB and JunB protein has also been demonstrated in T cells after induction ates the MAPK family member, JNK (5). Activated JNK then transactivates c-Jun by phosphorylation on two N-terminal of clonal anergy (1,3).
AP-1 is a heterodimer composed of Fos and Jun family serine residues. The lack of AP-1 transactivation observed in anergic T cells could therefore be due to impaired signaling members. During T cell activation, Fos and Jun are increased, and the Jun protein becomes phosphorylated (4). Two major in the pathways leading to activation of c-Fos and c-Jun, such as ERK and JNK pathways (6). However, the role of kinase pathways have been implicated in the activation of AP-1 during T cell responses to antigen, i.e. mitogen-activated c-Fos/AP-1 in the transcriptional activation of IL-2 has not been clearly defined, especially in relation to the contribution protein kinase (MAPK) and c-Jun N-terminal kinase (JNK).
of Jun and other regulatory elements such as the negative penicillin, 50 µg/ml streptomycin, 15 mM HEPES and 2 mM L-glutamine were stimulated with SEB in the presence of 30 regulatory element (NRE-A) (7).
Previous studies in this and other laboratories have shown Gy-irradiated syngeneic spleen cells (2ϫ10 5 /well) in a 96-well flat-bottomed culture plate for 4 days at 37°C in 5% CO 2 that features characteristic to rheumatoid joint destruction, including synovial overgrowth and bone resorption, are experiin humidified air. At the end of culture, the T cells were pulsed with 37 kBq of [ 3 H]thymidine (Dupont NEN, Boston, MA) and mentally produced by specifically augmenting c-fos gene expression (8-13). Expression of c-Fos/AP-1 is markedly [ 3 H]thymidine incorporation was determined by the scintillation technique. T cells were double labeled with biotinaugmented in rheumatoid joints (14, 15) and arthritic joint destruction can be ameliorated by selectively inhibiting tranconjugated anti-V β 8 mAb (F23.1) and FITC-streptavidin DCS (Vector, Burlingame, CA) and phycoerythrin (PE)-anti-TCRαβ scription of c-Fos/AP-1 (16), suggesting that activation of c-Fos/AP-1 is essentially important in arthritic joint destruction.
mAb or PE-anti-CD4 mAb (PharMingen, San Diego, CA) for flow cytometry. As to the question how c-Fos/AP-1 promoted joint destruction, previous studies indicate that c-Fos/AP-1 directly stimulates Expression vector synovial mesenchymal cells to release inflammatory cytokines such as IL-1, tumor necrosis factor-α and others (17-19), and A 4 kb BamHI fragment containing the murine c-fos genomic DNA was excised from the p75/15 plasmid (26) , and inserted invade cartilageous substrates as pannus (9,10). c-Fos/AP-1 also stimulated osteoblasts and osteoclasts to enhance into the BamHI site of the pH8 vector to construct the c-fos expression vector, 75/15pH8 (8). osteoclastic bone resorption (8, 11, 12) . Nevertheless, antigenspecific T cell response should be critically important at least T h 1 clone in the initiation of, and possibly in the perpetuation of, chronic arthritis (20) .
KLH-specific CD4 T h 1 clone 28-4 (27), a gift of Dr Y. Asano, Ehime University, Japan, was maintained in RPMI 1640 We have tested whether or not c-Fos/AP-1 plays an essential role in the induction of and resistance against anergy on medium supplemented with 10% FBS, 5% rat Con A supernatant (Collaborative Research, Bedford, MA), 50 µM 2-merantigen-specific T cell response in two ways. First, the T cell response against prior treatment with staphylococcus captoethanol, 50 U/ml penicillin and 50 µg/ml streptomycin (complete RPMI). Cells (1ϫ10 5 /ml) were stimulated with 50 enterotoxin B (SEB) was studied in vivo in H2-c-fos transgenic (fos) mice. Second, the in vitro response of keyhole limpet µg/ml of KLH (Calbiochem-Novabiochem, San Diego, CA) in the presence of 2ϫ10 6 /ml of mitomycin C-treated splenocytes hemocyanin (KLH)-specific T h 1 clone stably transfected with the c-fos gene was studied in relation to prior treatment with (APC) (28) of C3H/HeJ mice every 14 days. concanavalin A (Con A), since Con A binds the TCR and Stable c-fos transformant does not activate co-stimulatory pathways (1). We present direct evidence indicating that increased c-Fos/AP-1 confers T cells (1ϫ10 6 ) were isolated using lympholyte-M (Cedarlane) 9 days after stimulation with KLH and APC. They were resistance against antigen-specific unresponsiveness on CD4 T cells. The result is discussed in relation to the role of c-Fos/ suspended in 250 µl of saline G (137 mM NaCl, 5.4 mM KCl, 1.1 mM Na 2 HPO 4 , 0.86 mM KH 2 PO 4 , 0.49 mM MgCl 2 , 0.9 AP-1 in the induction of and resistance against anergy, and also in disease conditions such as rheumatoid arthritis in mM CaCl 2 and 6.1 mM glucose, pH 7.1) (29) containing 10 µg of pH8 or 75/15pH8 plasmids linearized with a ScaI which increased c-Fos/AP-1 has been shown to play an essential role in the pathogenesis of joint destruction. restriction enzyme. After incubation on ice for 10 min, electroporation was carried out in a 2 mm gap cuvette at 300 V for 99 µs for 8 times (eight pulses) using an Electro Square Methods Porator T820 (BTX, San Diego, CA). Cells were cultured in complete RPMI at 37°C for 2 days. Cells were stimulated with Mice KLH and APC, and subsequently cultured in complete RPMI C57BL/6 Cr Slc (B6) and C3H/HeJ mice were purchased containing 800 µg/ml of geneticin (Gibco/BRL, Grand Island, from Japan SLC (Hamamatsu, Shizuoka, Japan). fos mice NY), and then maintained in complete RPMI containing 100 carried the exogenous mouse c-fos gene under the control µg/ml of geneticin. of mouse MHC gene (H-2K b ) promoter (21) .
RT-PCR Tolerance induction
T cells were isolated at 2 h, and 3, 6 and 9 days after stimulation with KLH and APC. Total RNA was isolated using Mice were i.p. injected with 100 µg of SEB (Makor Chemicals, Jerusalem, Israel) once or twice at an interval of 7 days, i.p.
Isogen guanidium thiocyanate (30) (Nippon Gene, Toyama, Japan). Integration of DNA in transformants was confirmed injection followed by i.p. injection. We administered 2 times higher doses of SEB than others to tolerize mice (22, 23) . Nine using RT-PCR (Perkin Elmer, Norwalk, CT). RNA was reversely transcribed in a 20 µl reaction containing 2.5 µM of oligo days after final inoculation, T cells were isolated from spleen by passing though a nylon wool column followed by cytotoxic d(T) 16 , 5 mM MgCl 2 , 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 1 mM each of dATP, dCTP, dGTP and dTTP, 1 U/µl RNase treatment with mAb anti-CD8 (83.12.5) (24) , mAb anti-HSA (J11d.2) (25) and Low-Tox-M rabbit C (Cedarlane, Hornby, inhibitor, and sample RNA for 10 min. After adding 2.5 U/µl murine leukemia virus reverse transcriptase, this was incubOntario, Canada) at 37°C for 50 min (21) . V β 8 ϩ CD4 T cells (2ϫ10 5 /well) in α-MEM supplemented with 10% FBS (Whitated at 42°C for 20 min, at 99°C for 5 min and at 5°C for 5 min (cDNA). Then 100 µl reaction containing cDNA, 2 mM taker, Walkersville, MD), 50 µM 2-mercaptoethanol, 50 U/ml MgCl 2 , 10 mM Tris-HCl, pH 8.3, 50 mM KCl, 0.15 µM of with KLH and mitomycin C-treated splenocytes (5ϫ10 5 /2 ml/ well), which were depleted of T cells by using anti-Thy 1 mAb upstream primer, 0.15 µM of downstream primer and 2.5 U of AmpliTaq DNA polymerase (Perkin Elmer) was incubated (G7; PharMingen), anti-CD4 mAb (H129.19; PharMingen) and Lox-Tox-M rabbit C (32), in a 24-well plate (Sumitomo Bakelite). at 95°C for 1 min, at 53°C for 2 min and at 72°C for 2 min for 35 cycles. Aliquots of PCR products were electrophoresed in T h 1 cells were collected by using Dynabeads Mouse CD4 (Dynal, Oslo, Norway). Cells were suspended with 1 ml of a 1.5% agarose gel. The primers were 5Ј-CTTTTTGTCTTTTAT-TTCAG-3Ј (sense) and 5Ј-AGACAAAGGAAGACGTGTAA-3Ј PBS/1% FBS and incubated with 100 µl of Dynabeads Mouse CD4 for 20 min at 4°C. CD4 ϩ cells collected by a magnetic (antisense) for the exogenous c-fos (1.1 kbp), and 5Ј-GAGAT-TGCCAATCTGCTGAA-3Ј (sense) and 5Ј-AGACAAAGGAAGparticle concentrator (Dynal) were resuspended in 500 µl of hypotonic buffer (10 mM HEPES/KOH, pH 7.9, 1.5 mM MgCl 2 , ACGTGTAA-3Ј (antisense) for the exo-and endogenous cfos (488 bp). The β-actin primers were 5Ј-ACAACGGCTCCG-10 mM KCl, 0.5 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF, 1 µM leupeptin and 1 µM aprotinin) on ice for 10 min (32) . After GCATGTGCAA-3Ј (sense) and 5Ј-GCTCAGGAGGAGCAATG-ATCTTG-3Ј (antisense) (969 bp).
adding 5 µl of 10% NP-40, cells were incubated on ice for 20 min. The nuclear fraction was precipitated by centrifugation Western blot at 5000 r.p.m. for 3 min and resuspended in 50 µl of extraction buffer (20 mM HEPES/KOH, pH 7.9, 10% glycerol, 420 mM Purified T cells (1ϫ10 6 ) were dissolved in 50 µl of lysis buffer (10 mM Tris-HCl, pH 7.4, 3 mM MgCl 2 , 0.1% NP-40, 0.5 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF, 1 µM leupeptin and 1 µM aprotinin). This was incubated DTT and 1 mM PMSF) on ice for 10 min (31). The nuclear fraction was precipitated by centrifugation at 5000 r.p.m. for on ice for 30 min with agitation. Supernatant was obtained by centrifugation at 15,000 r.p.m. for 15 min and stored in 5 min and suspended in 50 µl of Laemmli buffer (62.5 mM Tris-HCl, pH 6.8, 10% glycerol, 2% SDS, 0.72 M 2-aliquots at -80°C (nuclear extract). mercaptoethanol and 0.00125% bromophenol blue). Proteins
Electrophoretic mobility shift assay (EMSA) were separated using 7.5 or 10% SDS-PAGE and transferred to an Immobilon-P membrane (Millipore, Bedford, MA). After Nuclear extract (5 µg) was incubated for 30 min with 0. TCTCAGTAGTCTTCTcc-5Ј. Double-stranded DNA of the nuclear factor of activated T cell (NFAT) binding site (33) was was visualized using the ECL system (Amersham).
5Ј-ccCCAAAGAGGAAAATTTGTTTCATACGAAAG-3Ј and 3Ј-
Induction of T cell unresponsiveness
GGTTTCTCCTTTTAAACAAAGTATGCTTTCcg-5Ј. The probe was end-labeled with DIG-11-ddUTP (Boehringer Mannheim, Unresponsiveness of T cells against re-challenge of antigen, so called anergy, was induced in T h 1 cells by pretreatment Mannheim, Germany). Non-labeled oligonucleotides (50 pmol) were added as competitor. The irrelevant doublewith Con A (Wako Pure Chemicals, Osaka, Japan) (1). T h 1 cells were cultured with Con A for 24 h. After adding 10 mg/ stranded DNA oligonucleotides were 5Ј-GTGTTACCCGCCT-ATGGAGGAGAA-3Ј and 5Ј-GGGTTCTCCTCCATACGCGGGml of α-methyl mannoside (Wako), cells were cultured for 5 days. Cells (2ϫ10 4 /200 µl/well) were isolated using TAA-3Ј (µ-oligo) (16). Supershift was performed by adding 5 µg of anti-c-Fos antibody (Ab-2; oncogene) or anti-NFAT lympholyte-M and placed in a 96-well microtiter plate (Sumitomo Bakelite, Tokyo, Japan). They were cultured with KLH antibody (sc-1151; Santa Cruz) to the binding reaction. After electrophoresis in a 4% polyacrylamide gel, oligonucleotides and 5ϫ10 5 /200 µl/well of APC for 24 h. IL-2 was measured using ELISA (BioSource, Camarillo, CA).
were transferred to positively charged nylon membrane (Boehringer). DIG-labeled oligonucleotide was visualized by Flow cytometry alkaline phosphatase-labeled Fab anti-DIG antibody, followed by chemiluminescence reaction using 100 µg/ml CSPD sub-T cells (2ϫ10 5 /50 µl) with or without pretreatment with Con A (0.4 µg/ml) were incubated with FITC-hamster IgG mAb antistrate (Tropix, Bedford, MA). CD28 (37.51.1; Serotec, Oxford, UK) and PE-rat IgG1 mAb MAPK activity anti-IL-2 receptor α chain (PC61.5.3; Serotec) for 20 min. Fluorescence intensity of T cells was measured in FACStar KLH-specific T cells (2ϫ10 5 /2 ml/well) with or without pretreatment with Con A were cultured for 4 h with KLH and mitomycin Plus (Becton Dickinson, San Jose, CA).
C-treated, T cell-depleted, splenocytes (5ϫ10 5 /2 ml/well) in Preparation of nuclear extract a 24-well plate. KLH-specific T cells were collected by using Dynabeads Mouse CD4. They were suspended in 500 µl of T cells (3ϫ10 6 /2 ml/well) isolated from SEB-or PBS-pretreated mice were cultured for 20 h with SEB (5 µg/ml) in the presence MAPK lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium of 30 Gy-irradiated syngeneic spleen cells (3ϫ10 6 /2 ml/well) in a 24-well plate. KLH-specific T cells (2ϫ10 5 /2 ml/well) with pyrophosphate, 1 mM β-glycerolphosphate, 1 mM Na 3 VO 4 , 1 µg/ml leupeptin, and 1 mM PMSF) on ice for 5 min. or without pretreatment with Con A were cultured for 20 h After sonication using MICROSON (MS50; Heat SystemsUltrasonics, Farmingdale, NY), the soluble fraction was obtained by centrifugation at 12,000 r.p.m. for 10 min. Then 200 µg of proteins in 200 µl MAPK lysis buffer was incubated with 2 µl anti-phospho-specific p44/42 MAPK (Thr202/Tyr204) mAb (9105; New England Biolabs, Beverly, MA) at 4°C overnight and then incubated with 50 µl Protein A-agarose beads (Boehringer) at 4°C overnight. The beads were washed twice with MAPK lysis buffer and twice with kinase buffer (25 mM Tris-HCl, pH 7.5, 5 mM β-glycerolphosphate, 2 mM DTT, 0.1 mM Na 3 VO 4 and 10 mM MgCl 2 ), and then suspended in 25 µl kinase buffer supplemented with 200 µM ATP and 1 µg Elk1 fusion protein (9184; New England Biolabs). The reaction was carried out at 30°C for 30 min and terminated with 12.5 was incubated with anti-phospho-specific Elk1(Ser 383) mAb (9181; New England Biolabs), followed by the reaction with horseradish peroxidase-conjugated anti-rabbit Ig antibody (Amersham). Bound antibody was visualized by the ECL system.
Results
fos mice are resistant to anergy induction in vivo
There are two major mechanisms by which a high dose of SEB induces antigen-specific T cell tolerance: activationinduced cell death (34) and anergy (34-36). The proportion of SEB-reactive V β 8 ϩ T cells in the TCRαβ ϩ CD4 T cell population was 24.6 Ϯ 1.1% (n ϭ 4) in control B6 mice. It decreased to 19.7 Ϯ 1.1% (n ϭ 4) 9 days after administration of 100 µg SEB once. The proportion of V β 8 ϩ T cells in the TCRαβ ϩ CD4 T cell population was basically higher at 28.2% (n ϭ 2) in fos mice and it decreased to 20.2 % (n ϭ 2) after the inoculation of SEB. Thus, the activation-induced cell death occurred both in B6 and fos mice.
B6 and fos mice were next inoculated with 100 µg SEB twice at an interval of 7 days to tolerize SEB-reactive T cells in vivo (22, 23) . Nine days after this treatment, the proportion of V β 8 ϩ T cells in the CD4 T cell population decreased to isolated from SEB-or PBS-pretreated B6 or fos mice were cultured for 20 h with SEB (5 µg/ml) in the presence of 30 Gy-irradiated similar levels: 18.9 Ϯ 2.6 % (n ϭ 3) in B6 mice and 20.2 Ϯ syngeneic spleen cells (3ϫ10 6 /2 ml/well). Nuclear extracts of T cells 3.4 % (n ϭ 4) in fos mice. In SEB-treated B6 mice, T cell collected by using Dynabeads Mouse CD4 were incubated with DIGproliferation in vitro against SEB was reduced by 90% or labeled AP-1 oligonucleotides. The competition assay was performed more (Fig. 1a) . In contrast, the reduction was less significant by adding unlabeled oligonucleotides (designated as comp-oligo).
in SEB-treated fos mice as compared with those of B6 mice Supershift was perrformed for c-Fos by adding specific antibody. (Fig. 1b). EMSA showed that the level of AP-1 was high in the T cells of fos mice and it was not decreased by the pretreatment with SEB in the fos mice (Fig. 2) . Thus, the resistance of were produced by 75/15pH8 cells, while pH8 T cells in a T cells against anergy in fos mice appeared to depend on quiescent state, when cultured for 9 days after antigen the AP-1 level.
stimulation, did not produce detectable amounts of c-Fos protein (Fig. 3b) . The amount of c-Jun and JunB was similar Antigen-specific T h 1 cells that overexpress c-fos are resistant between pH8 and 75/15pH8 clones, while JunD was undetectto anergy induction in vitro able 9 days after antigen stimulation (Fig. 3b) . The amount of c-Jun, JunB and JunD was increased 20 h after antigen We studied the detailed mechanism of action of c-Fos/AP-1 against anergy induction in in vitro experiments. The exogenstimulation, whereas the amount of these proteins remained similar between pH8 and 75/15pH8 clones (Fig. 3c) . At 20 h ously introduced c-fos gene was expressed constitutively in 75/15pH8 T cells (Fig. 3a) . Increased amounts of c-Fos protein after antigen stimulation, increased amount of c-Fos protein was detected in 75/15pH8 cells as compared with pH8 cells (Fig. 3c) . IL-2 was produced from both pH8 and 75/15pH8 T cells after stimulation with KLH and APC (Fig. 4a) . However, KLHspecific T h 1 cells produced decreasing amounts of IL-2 in response to KLH after the pretreatment of increasing amounts of Con A (Fig. 4b) . Inhibition of IL-2 production after pretreatment with Con A was less significant in 75/15pH8 T cells as compared with those in control pH8 T cells. Surface expression of CD28 or IL-2 receptor α before and after treatment with Con A was similar between two types of T cell clones (data not shown).
EMSA showed that the level of transcription factor AP-1 increased in 75/15pH8 cells after stimulation with KLH as compared with pH8 cells (Fig. 5a, lane 1 versus lane 3) . The AP-1 was super-shifted by the treatment with anti-Fos antibody (Fig. 5a, lane 7) . The level of AP-1 was depressed in Con A- (Fig. 5a, lanes 1-4) . The level of transcription factor cultured with KLH (0, 10, 50 or 100 µg/ml) and T cell-depleted, NFAT in the nuclear extract, i.e. activated form of NFAT in (Fig. 5b, lanes 1-4) . Thus, overexpression of AP-1 into the nucleus in anergized T h 1 clone. . EMSA for transcription factor AP-1 and NFAT. The 75/15pH8 T or pH8 T cells (2ϫ10 5 /2 ml/well) with or without pretreatment with 0.4 µg/ml of Con A were stimulated with KLH (50 µg/ml) and T cell-depleted, mitomycin C-treated splenocytes (APC) (5ϫ10 6 /2 ml/well) for 20 h. Nuclear extracts were prepared from T cells collected by using Dynabeads Mouse CD4. Nuclear extracts 20 h after the stimulation with KLH and APC were reacted with DIG-labeled AP-1 oligonucleotides or NFAT oligonucleotides (a and b). Competition assay was done by adding unlabeled oligonucleotides (designated as comp-oligo) and unlabeled irrelevant oligonucleotides (µ-oligo). Supershift was done for c-Fos and NFAT by adding specific antibodies. The data presented were representative of three independent experiments.
T cells (Fig. 6) , indicating that increased c-Fos/AP-1 seems to have modified the upper pathway of cellular signal transduction rather than simply recruiting AP-1 onto the IL-2 promoter.
Discussion
The results directly show that antigen-specific T cells become resistant against anergy induction when c-fos gene is overexpressed. Previous studies have shown that anergic T cells stimulated with APC show defective AP-1-dependent transcription as well as suboptimal binding of AP-1 to the element within the regulatory region of the IL-2 gene (1,2). The amount of c-Fos, FosB and JunB was significantly depressed in anergized T cells (1,3). These findings suggest that T cell T cells (Fig. 5) . The amount of NFAT/AP-1 also did not (Ser 383) mAb and detected by chemiluminescence. decrease in Con A-treated 75/15pH8 T cells. AP-1 forms a complex with the activated form of NFAT which was in the nuclei and NFAT acts as a major transcription factor for IL-2 Effect of c-fos on MAPK gene expression (37, 38). According to recent studies, it appears that NFAT complexed with AP-1 acts on the IL-2 We next measured the MAPK activity in the T cells with or without pretreatment with Con A. The result showed that promoter in anergized T cells (39) . These observations are consistent with the present result. We found that surface MAPK activity did not decrease in 75/15pH8 T cells by pretreatment with Con A, whereas it did decrease in pH8 expression of accessory molecules, CD28 and IL-2 receptor, Jun is also blocked through impairment of ERK in anergic
